Clinical Trials Directory

Trials / Completed

CompletedNCT04249505

Refractive Accuracy of "2WIN" and Portable Autorefractors

The Refractive Accuracy of Photoscreeners "2WIN" and "PlusoptiX" and the "Retinomax" Auto Refractor

Status
Completed
Phase
Study type
Observational
Enrollment
708 (actual)
Sponsor
Alaska Blind Child Discovery · Academic / Other
Sex
All
Age
6 Months – 95 Years
Healthy volunteers
Accepted

Summary

Youth and some adults have photoscreening refractions and hand-held auto refraction before cycloplegia refraction during new and follow up eye examinations. Vector math is applied to each refraction to determine how closely the hand-held "dry" devices match actual refraction.

Detailed description

A closeness-of-fit algorithm utilizing vector transformations of astigmatism is designed and applied to 50-years of clinical international refractive experience. As a part of new and follow up comprehensive eye examinations, patients and parents consented to confirm the cycloplegic refraction to other portable refractive tools. The ability of photoscreeners "2WIN" ("Adaptica," Padova italy), "PlusoptiX A12" (Nuremberg, Germany) and "Retinomax" (Righton, Tokyo, Japan) to match actual refraction is assessed utilizing the new algorithm. This algorithm could then be applied to batches of donated spectacles distend by charitable organizations worldwide if portable auto refracting devices are employed.

Conditions

Interventions

TypeNameDescription
DEVICE"2WIN" Photoscreenernon-cycloplegia refraction by Adaptica "2WIN"
DEVICE"Plusoptix A12"non-cycloplegic refraction by "Plusoptix A12" photoscreener
DEVICE"Retinomax"non-cycloplegic refraction by "Retinomax K+" auto refractor

Timeline

Start date
2020-01-09
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2020-01-31
Last updated
2021-07-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04249505. Inclusion in this directory is not an endorsement.

Refractive Accuracy of "2WIN" and Portable Autorefractors (NCT04249505) · Clinical Trials Directory